Drugs / Cyclosporine (CSP)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00568633 Background | Aug 2007 → Dec 2015 | acute myeloid leukemia | Stanford University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cyclosporine (CSP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00568633 ↗ |
| Route | Oral | “6.25 mg/kg twice daily oral” NCT00568633 ↗ |